IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs

Proteolysis‐targeting chimera (PROTAC) has become a very important means of protein degradation and a new way of disease treatment. In particular, PROTACs constructed with ligands for E3 ligase cereblon account for more than 90 % of the PROTACs currently in clinical research. Notably, CRBN ligands t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chembiochem : a European journal of chemical biology 2024-08, Vol.25 (16)
1. Verfasser:	Li, Minglei
Format:	Artikel
Sprache:	eng
Schlagworte:	Biodegradation Chimeras Degradation Ligands Medical treatment Proteins Proteolysis Substrates Ubiquitin-protein ligase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	16
container_start_page
container_title	Chembiochem : a European journal of chemical biology
container_volume	25
creator	Li, Minglei
description	Proteolysis‐targeting chimera (PROTAC) has become a very important means of protein degradation and a new way of disease treatment. In particular, PROTACs constructed with ligands for E3 ligase cereblon account for more than 90 % of the PROTACs currently in clinical research. Notably, CRBN ligands themselves are a class of molecular glue compounds capable of degrading neo‐substrate proteins. Compared to the target proteins degradation, the degradation of neo‐substrates, especially IKZF2, has not received enough attention. Therefore, this review summarizes the currently published IKZF2 degraders derived from articles and patents, which are conducive to the design of PROTACs with desired IKZF2 degradation from the perspective of medicinal chemistry.
doi_str_mv	10.1002/cbic.202400365
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3094447255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3094447255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c152t-1e0383a997e672219ee2952c3baed777f6fea635801690ede5530cb460dad7dd3</originalsourceid><addsrcrecordid>eNo9kMtOAjEYhRujiYhuXTdxPdjLTEvdIYoSSTBmjIkLJ532HyxCB9th4Y5H8Fl8JJ7EMRBX5yzOJfkQOqekRwlhl6Z0pscISwnhIjtAHZpylUjB-eHep4zJY3QS45wQogSnHfQ2fngdMXwDs6Ctblztr_C42W5-Is7dEnBT41x_AHa-dQNj6rVvsGvwyzv4thXdzDs_w0MIUC5qv918X-sIFj8-TfPBMJ6io0ovIpzttYueR7f58D6ZTO_Gw8EkMTRjTUKB8D7XSkkQkjGqAJjKmOGlBiulrEQFWvCsT6hQBCxkGSemTAWx2kpreRdd7HZXof5cQ2yKeb0Ovr0sOFFpmkrWVrqot0uZUMcYoCpWwS11-CooKf4YFn8Mi3-G_BeEY2Sv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3094447255</pqid></control><display><type>article</type><title>IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Li, Minglei</creator><creatorcontrib>Li, Minglei</creatorcontrib><description>Proteolysis‐targeting chimera (PROTAC) has become a very important means of protein degradation and a new way of disease treatment. In particular, PROTACs constructed with ligands for E3 ligase cereblon account for more than 90 % of the PROTACs currently in clinical research. Notably, CRBN ligands themselves are a class of molecular glue compounds capable of degrading neo‐substrate proteins. Compared to the target proteins degradation, the degradation of neo‐substrates, especially IKZF2, has not received enough attention. Therefore, this review summarizes the currently published IKZF2 degraders derived from articles and patents, which are conducive to the design of PROTACs with desired IKZF2 degradation from the perspective of medicinal chemistry.</description><identifier>ISSN: 1439-4227</identifier><identifier>EISSN: 1439-7633</identifier><identifier>DOI: 10.1002/cbic.202400365</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>Biodegradation ; Chimeras ; Degradation ; Ligands ; Medical treatment ; Proteins ; Proteolysis ; Substrates ; Ubiquitin-protein ligase</subject><ispartof>Chembiochem : a European journal of chemical biology, 2024-08, Vol.25 (16)</ispartof><rights>2024 Wiley-VCH GmbH</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c152t-1e0383a997e672219ee2952c3baed777f6fea635801690ede5530cb460dad7dd3</cites><orcidid>0000-0002-8381-2455</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids></links><search><creatorcontrib>Li, Minglei</creatorcontrib><title>IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs</title><title>Chembiochem : a European journal of chemical biology</title><description>Proteolysis‐targeting chimera (PROTAC) has become a very important means of protein degradation and a new way of disease treatment. In particular, PROTACs constructed with ligands for E3 ligase cereblon account for more than 90 % of the PROTACs currently in clinical research. Notably, CRBN ligands themselves are a class of molecular glue compounds capable of degrading neo‐substrate proteins. Compared to the target proteins degradation, the degradation of neo‐substrates, especially IKZF2, has not received enough attention. Therefore, this review summarizes the currently published IKZF2 degraders derived from articles and patents, which are conducive to the design of PROTACs with desired IKZF2 degradation from the perspective of medicinal chemistry.</description><subject>Biodegradation</subject><subject>Chimeras</subject><subject>Degradation</subject><subject>Ligands</subject><subject>Medical treatment</subject><subject>Proteins</subject><subject>Proteolysis</subject><subject>Substrates</subject><subject>Ubiquitin-protein ligase</subject><issn>1439-4227</issn><issn>1439-7633</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOAjEYhRujiYhuXTdxPdjLTEvdIYoSSTBmjIkLJ532HyxCB9th4Y5H8Fl8JJ7EMRBX5yzOJfkQOqekRwlhl6Z0pscISwnhIjtAHZpylUjB-eHep4zJY3QS45wQogSnHfQ2fngdMXwDs6Ctblztr_C42W5-Is7dEnBT41x_AHa-dQNj6rVvsGvwyzv4thXdzDs_w0MIUC5qv918X-sIFj8-TfPBMJ6io0ovIpzttYueR7f58D6ZTO_Gw8EkMTRjTUKB8D7XSkkQkjGqAJjKmOGlBiulrEQFWvCsT6hQBCxkGSemTAWx2kpreRdd7HZXof5cQ2yKeb0Ovr0sOFFpmkrWVrqot0uZUMcYoCpWwS11-CooKf4YFn8Mi3-G_BeEY2Sv</recordid><startdate>20240819</startdate><enddate>20240819</enddate><creator>Li, Minglei</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><orcidid>https://orcid.org/0000-0002-8381-2455</orcidid></search><sort><creationdate>20240819</creationdate><title>IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs</title><author>Li, Minglei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c152t-1e0383a997e672219ee2952c3baed777f6fea635801690ede5530cb460dad7dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biodegradation</topic><topic>Chimeras</topic><topic>Degradation</topic><topic>Ligands</topic><topic>Medical treatment</topic><topic>Proteins</topic><topic>Proteolysis</topic><topic>Substrates</topic><topic>Ubiquitin-protein ligase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Minglei</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Chembiochem : a European journal of chemical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Minglei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs</atitle><jtitle>Chembiochem : a European journal of chemical biology</jtitle><date>2024-08-19</date><risdate>2024</risdate><volume>25</volume><issue>16</issue><issn>1439-4227</issn><eissn>1439-7633</eissn><abstract>Proteolysis‐targeting chimera (PROTAC) has become a very important means of protein degradation and a new way of disease treatment. In particular, PROTACs constructed with ligands for E3 ligase cereblon account for more than 90 % of the PROTACs currently in clinical research. Notably, CRBN ligands themselves are a class of molecular glue compounds capable of degrading neo‐substrate proteins. Compared to the target proteins degradation, the degradation of neo‐substrates, especially IKZF2, has not received enough attention. Therefore, this review summarizes the currently published IKZF2 degraders derived from articles and patents, which are conducive to the design of PROTACs with desired IKZF2 degradation from the perspective of medicinal chemistry.</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/cbic.202400365</doi><orcidid>https://orcid.org/0000-0002-8381-2455</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 1439-4227
ispartof	Chembiochem : a European journal of chemical biology, 2024-08, Vol.25 (16)
issn	1439-4227 1439-7633
language	eng
recordid	cdi_proquest_journals_3094447255
source	Wiley Online Library Journals Frontfile Complete
subjects	Biodegradation Chimeras Degradation Ligands Medical treatment Proteins Proteolysis Substrates Ubiquitin-protein ligase
title	IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A19%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IKZF2%20Degradation:%20It%E2%80%B2s%20Time%20to%20Take%20into%20Account%20it%20When%20Designing%20Cereblon%E2%80%90Based%20PROTACs&rft.jtitle=Chembiochem%20:%20a%20European%20journal%20of%20chemical%20biology&rft.au=Li,%20Minglei&rft.date=2024-08-19&rft.volume=25&rft.issue=16&rft.issn=1439-4227&rft.eissn=1439-7633&rft_id=info:doi/10.1002/cbic.202400365&rft_dat=%3Cproquest_cross%3E3094447255%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3094447255&rft_id=info:pmid/&rfr_iscdi=true